Home > Boards > US Listed > Biotechs > Actinium Pharmaceuticals, Inc. (ATNM)

Seems like a very simple value proposition. Fits

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
stockguard Member Profile
 
Followed By 21
Posts 1,606
Boards Moderated 0
Alias Born 07/09/05
160x600 placeholder
Quarterly Report (10-q) Edgar (US Regulatory) - 5/14/2021 5:01:48 PM
Annual Report (10-k) Edgar (US Regulatory) - 3/31/2021 5:01:49 PM
Actinium initiates patient enrollment in Iomab-ACT trial prior to CD19 CAR t-cell therapy Seeking Alpha - 3/24/2021 8:10:31 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/12/2021 4:45:42 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/20/2020 5:01:19 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 10/28/2020 4:18:50 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/28/2020 4:16:20 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 10/23/2020 5:02:55 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 10/7/2020 5:02:07 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 10/7/2020 5:01:10 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 8/17/2020 6:21:29 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/14/2020 5:23:14 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/14/2020 5:22:57 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/14/2020 5:19:46 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/14/2020 5:18:39 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/14/2020 5:07:34 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/14/2020 5:05:34 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/14/2020 5:05:13 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/14/2020 5:04:54 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/14/2020 5:03:59 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 8/12/2020 6:01:18 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/5/2020 4:32:08 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/24/2020 5:11:05 PM
Amended Annual Report (10-k/a) Edgar (US Regulatory) - 7/13/2020 5:10:51 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 6/30/2020 6:32:21 AM
stockguard   Sunday, 01/03/21 01:57:15 PM
Re: timberwolf7 post# 2547
Post # of 2570 
Seems like a very simple value proposition. Fits my sweet spot of being scientifically de-risked. Radiotherapy is a very real thing now in other areas, oncology definitely lends itself to it. Can hit both CD 45 and CD 33 and will be able to do both at once as well. Have shown dose response as expected. Side effects superior to alternative treatments. Safe for patients over 60. About a $100 M MC. Tiny company has this therapy in 10 of the largest transplant centers across the US which bodes well if/once approved.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences